Navigation Links
ActiGraph Announces Heart Rate Variability Measurement Support
Date:1/28/2013

Pensacola, FL (PRWEB) January 28, 2013

ActiGraph, a leading provider of objective patient monitoring solutions for the global research community, announced today that it now supports the collection of heart rate variability measurements with the release of its ActiLife software version 6.5.

ActiGraph’s newest generation of wireless activity monitoring devices can now be paired with a compatible wireless heart rate monitor to deliver heart rate RR intervals in addition to beats per minute and objective physical activity and sleep/wake measurements such as energy expenditure, activity intensity, steps taken, amount of sleep and body position. Heart rate RR intervals, which are the intervals of time that elapse between the R-waves (peaks) of successive heartbeats, can be used to determine how the variation between consecutive heartbeats changes over time. Heart rate variability is widely regarded as a strong predictor of survival after heart attack and provides valuable insight on nervous system activity and cardiovascular health.

“Many of our clients are involved in research studies and clinical trials involving cardiovascular health and related diseases, so the ability to capture and synchronize heart rate RR intervals with objective physical activity and sleep/wake data is of tremendous value,” said John Schneider, Senior Vice President of Research and Development at ActiGraph. “Heart rate variability measurements add an exciting new dimension to traditional actigraphy data, and we’ve integrated this capability into our existing solution with minimal added cost or burden to the research team and study subjects.”

About ActiGraph
ActiGraph’s extensively validated suite of hardware and software products are widely used by prominent scientific and academic organizations in more than 65 countries in research studies and clinical trials involving physical activity, energy expenditure, and sleep/wake behavior and their relationships to a wide range of health conditions including obesity, diabetes, cancer, cardiovascular disease and sleep disorders. ActiGraph monitoring solutions have delivered objective activity and sleep data to many high profile population studies including the National Health and Nutrition Examination Survey (NHANES), the European Youth Health Study, the U.K. Millennium Cohort Study and the Women’s Health Initiative.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10362395.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ActiGraph Launches ActiLife Mobile App
2. DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
3. Carolina Conceptions Announces the Delivery of their First Egg Freeze Pregnancy
4. PhaseRx Announces Technology Evaluation Agreement with Monsanto
5. Taylor-Wharton Announces Release of New Toro Line of Animal Artificial Insemination Products
6. Sigma-Aldrich Announces Q4 2012 Earnings Conference Call
7. Oramed Pharmaceuticals Announces Reverse Stock Split
8. Kenrico Announces Records of Patents for 2012 and Financial Targets for 2013
9. Cato Research and Cato BioVentures Announces the Opening of Houston, Texas, Office
10. PharmaDirections Announces Appointment of Dr. Bruce Rehlaender as Principal, Formulation Development
11. NSG Announces New Quartz Micro Flow Channel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):